Conducting a COVID-19 drug and vaccine clinical trial

Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Conduite d'un essai clinique du médicament et du vaccin COVID-19
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-05-01 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["COVID-19", "pandémie", "essais cliniques", "médicaments", "vaccin", "demande d'autorisation d'essai", "Règlement sur les instruments médicaux", "arrêté provisoire pour essais cliniques de médicaments et de vaccins liés à COVID-19"], "en": ["COVID-19", "pandemic", "clinical trials", "drugs", "vaccine", "apply for a trial authorization", "Medical Devices Regulations", "interim order for clinical trials for drug and vaccine related to COVID-19"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source